171 related articles for article (PubMed ID: 14727458)
1. Colchicine-induced leukopenia in a patient with familial Mediterranean fever: the cause and a possible approach.
Ben-Chetrit E; Navon P
Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S38-40. PubMed ID: 14727458
[TBL] [Abstract][Full Text] [Related]
2. Colchicine and Leukopenia: Clinical Implications.
Sag E; Bayindir Y; Adiguzel A; Demir S; Bilginer Y; Aytac S; Ozen S
J Pediatr; 2020 Sep; 224():166-170.e1. PubMed ID: 32417084
[TBL] [Abstract][Full Text] [Related]
3. Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review.
Talerico R; Cardillo C; De Vito F; Schinzari F; Soldato M; Giustiniani MC; Verrecchia E; Manna R
Front Immunol; 2020; 11():889. PubMed ID: 32477360
[TBL] [Abstract][Full Text] [Related]
4. Colchicine treatment in children with familial Mediterranean fever.
Ozkaya N; Yalçinkaya F
Clin Rheumatol; 2003 Oct; 22(4-5):314-7. PubMed ID: 14579163
[TBL] [Abstract][Full Text] [Related]
5. Colchicine is a safe drug in children with familial Mediterranean fever.
Padeh S; Gerstein M; Berkun Y
J Pediatr; 2012 Dec; 161(6):1142-6. PubMed ID: 22738946
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based recommendations for the practical management of Familial Mediterranean Fever.
Hentgen V; Grateau G; Kone-Paut I; Livneh A; Padeh S; Rozenbaum M; Amselem S; Gershoni-Baruch R; Touitou I; Ben-Chetrit E
Semin Arthritis Rheum; 2013 Dec; 43(3):387-91. PubMed ID: 23742958
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of interferon-alpha in a patient with resistant familial Mediterranean fever complicated by polyarteritis nodosa.
Calguneri M; Apras S; Ozbalkan Z; Ozturk MA
Intern Med; 2004 Jul; 43(7):612-4. PubMed ID: 15335192
[TBL] [Abstract][Full Text] [Related]
8. Colchicine-induced myopathy in a teenager with familial Mediterranean fever.
Sayarlioglu M; Sayarlioglu H; Ozen S; Erkoc R; Gul A
Ann Pharmacother; 2003 Dec; 37(12):1821-4. PubMed ID: 14632592
[TBL] [Abstract][Full Text] [Related]
9. Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients.
Ozen F; Silan C; Uludag A; Candan F; Silan F; Ozdemir S; Atik S; Ozdemir O
Ren Fail; 2011; 33(9):899-903. PubMed ID: 21851199
[TBL] [Abstract][Full Text] [Related]
10. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.
Duzova A; Bakkaloglu A; Besbas N; Topaloglu R; Ozen S; Ozaltin F; Bassoy Y; Yilmaz E
Clin Exp Rheumatol; 2003; 21(4):509-14. PubMed ID: 12942707
[TBL] [Abstract][Full Text] [Related]
11. Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients.
Haj Yahia S; Ben Zvi I; Livneh A
Rheumatol Int; 2018 Jan; 38(1):141-147. PubMed ID: 28975396
[TBL] [Abstract][Full Text] [Related]
12. Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increase.
Knieper AM; Klotsche J; Lainka E; Berger T; Dressler F; Jansson AF; Rietschel C; Oommen PT; Berendes R; Niehues T; Neudorf U; Foell D; Wittkowski H; Kallinich T
Rheumatology (Oxford); 2017 Sep; 56(9):1597-1606. PubMed ID: 28859329
[TBL] [Abstract][Full Text] [Related]
13. Current trends in colchicine treatment in familial Mediterranean fever.
La Regina M; Ben-Chetrit E; Gasparyan AY; Livneh A; Ozdogan H; Manna R
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):41-6. PubMed ID: 24064013
[TBL] [Abstract][Full Text] [Related]
14. Semen analysis in adolescents with familial Mediterranean fever.
Kaya Aksoy G; Koyun M; Usta MF; Çomak E; Akman S
J Pediatr Urol; 2019 Aug; 15(4):342.e1-342.e7. PubMed ID: 31036478
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic approach to familial Mediterranean fever: a review update.
Ozturk MA; Kanbay M; Kasapoglu B; Onat AM; Guz G; Furst DE; Ben-Chetrit E
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S77-86. PubMed ID: 21968242
[TBL] [Abstract][Full Text] [Related]
16. Vitamin B12 levels in familial Mediterranean fever patients treated with colchicine.
Gemici AI; Sevindik ÖG; Akar S; Tunca M
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):57-9. PubMed ID: 24064015
[TBL] [Abstract][Full Text] [Related]
17. The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever.
Yoldaş TÇ; Çakar N; Başaran Ö; Acar B; Uncu N; Çaycı FŞ
Clin Rheumatol; 2016 Jun; 35(6):1603-7. PubMed ID: 26384820
[TBL] [Abstract][Full Text] [Related]
18. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement.
Kallinich T; Haffner D; Niehues T; Huss K; Lainka E; Neudorf U; Schaefer C; Stojanov S; Timmann C; Keitzer R; Ozdogan H; Ozen S
Pediatrics; 2007 Feb; 119(2):e474-83. PubMed ID: 17242135
[TBL] [Abstract][Full Text] [Related]
19. Once-daily use of colchicine in children with familial Mediterranean fever.
Koşan C; Ozkan B
Clin Pediatr (Phila); 2004 Sep; 43(7):605-8. PubMed ID: 15378145
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of intermittent colchicine therapy in familial Mediterranean fever.
Wright DG; Wolff SM; Fauci AS; Alling DW
Ann Intern Med; 1977 Feb; 86(2):162-5. PubMed ID: 319724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
